A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

NCT03125213 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision.

Conditions

Hepatitis B, Chronic

Interventions

DRUG: AL-3778
DRUG: Peginterferon Alfa-2A
DRUG: Placebo Oral Tablet

Sponsor

Alios Biopharma Inc.